Evidence-based management guidelines for noncystic fibrosis bronchiectasis in children and adolescents

Eun Lee1, Kyunghoon Kim2, You Hoon Jeon3

  • 1Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.

PubMed

Insights

This study provides evidence-based guidelines for managing non-cystic fibrosis bronchiectasis in children. It addresses treatment and prevention of exacerbations, crucial for improving outcomes in pediatric respiratory illness.

Area of Science:

  • Pediatric Respiratory Medicine
  • Clinical Guidelines Development

Background:

  • Non-cystic fibrosis bronchiectasis (NCFB) is a chronic respiratory condition with significant health and economic impacts.
  • Effective management of NCFB requires early recognition and proactive treatment/prevention of exacerbations.
  • Limited evidence exists for NCFB exacerbation management, particularly in pediatric populations.

Purpose of the Study:

  • To develop evidence- and consensus-based guidelines for NCFB treatment in children and adolescents.
  • To provide recommendations for medical and non-medical management strategies.
  • To address critical aspects of NCFB care, including antibiotic use and airway clearance.

Main Methods:

  • Utilized methods recommended by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) working group.
  • Systematic review of evidence published up to July 2, 2020.
  • Incorporated expert opinions to supplement evidence where limited.

Main Results:

  • Established comprehensive guidelines for pediatric NCFB management.
  • Provided recommendations on antibiotic therapy and airway clearance techniques.
  • Highlighted areas with limited evidence requiring further research.

Conclusions:

  • The developed guidelines offer crucial support for clinicians managing NCFB in children and adolescents.
  • Further large-scale, well-designed studies are needed to strengthen evidence-based management strategies.
  • These guidelines aim to improve clinical outcomes for pediatric patients with NCFB.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
164
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
3.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442